In this work, solid lipid nanoparticles (SLN) have been prepared from water-in-oil-in-water double emulsion, using monocaprate as solid lipid, sorbitan monooleate (Span 80) and polyoxyethylene sorbitan monolaurate (Tween 20) as emulsifier, and puerarin as target drug. The morphology of SLN with drug loaded or not was investigated by the transmission electron microscope (TEM). The crystal order and structure of particles were studied by differential scanning calorimetry (DSC) and wide angle X-ray diffraction (WAXD), respectively. The results indicate that the diameters of SLN with puerarin inside are larger than those without drugs. The analysis of WAXD and DSC shows that the state of crystallinity SLN prepared by double emulsion method was worse than that of SLN prepared by microemulsion. And also the drug-loaded SLN presents a less ordered crystallinity than the drug-free SLN. But both the drug-free and drug-loaded SLN exist in an amorphous state. The reasons of the phenomenon have been discussed.
Karavas E Georgarakis E Bikiaris D . Adjusting drug release by using miscible polymer blends as effective drug carries. J Therm Anal Calorim. 2006; 84: 125–33 .
Sabín J Prieto G Sennato S Blanco E Messina PV Ruso JM , et al. Examination of the influence of F6H10 fluorinated diblocks on DPPC liposomes. J Therm Anal Calorim. 2007;87: 301–4 .
Müller RH Mader K Gohla S . Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm. 2000; 50: 161–77 .
Liu J Gong T Wang C Zhong Z Zhang Z . Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm. 2007; 340: 153–62 .
Lamprecht A Ubrich N Hombreir Pérez M Lehr C-M Hoffman M Maincent P . Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm. 2000; 196: 177–82 .
Chueh FS Chang CP Chio CC Lin MT . Puerarin acts through brain serotonergic mechanisms to induce thermal effects. J Pharmacol Sci. 2004; 96: 420–7 .
Song XP Chen PP Chai XS . Effects of puerarin on blood pressure and plasma rennin activity in spontaneously hypertensive rats. Acta Pharmacol Sin. 1988; 9: 55–8.
Li Y Yang Y . Clinical treatment by puerarin in patients with senile ischemic cerebrovascular disease. Chin Pharm J. 1997; 32: 776–7.
Liu Q Lu Z Wang L . Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism. J Tongji Med Univ. 2000; 20: 43–5.
Sherman P Parkinson C . Mechanism of temperature induced phase inversion in O/W emulsions stabilised by O/W and W/O emulsifier blends. Prog Colloid Polym Sci. 1978; 63: 10–4 .
Dokic P Sherman P . Study on thermal induced phase inversion of concentrated O/W emulsions stabilized by various Tween emulsifiers. Colloid Polym Sci. 1980; 258: 1159–63 .
Pal R . Viscosity models for multiple emulsions. Food Hydrocolloid. 2008; 22: 428–38 .
Garti N Bisperink C . Double emulsions: progress and applications. Curr Opin Colloid Interface Sci. 1998; 3: 657–67 .
Mandawgade SD Patravale VB . Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm. 2008; 363: 132–8 .
Müller RH Radtke M Wissing SA . Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliver Rev. 2002; 54 (Suppl 1):S131–S155 .
Wissing SA Kayser O Müller RH . Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliver Rev. 2004; 56: 1257–72 .
Mehnert W Mäder K . Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliver Rev. 2001; 47: 165–96 .
Papadimitriou S Bikiaris D Avgoustakis K Karavas E Georgarakis M . Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym. 2008; 73: 44–54 .
Cavalli R Trotta F Carlotti EM Possetti B Trotta M . Nanoparticles derived from amphiphilic β-cyclodextrin. J Incl Phenom Macrocycl Chem. 2007; 57: 657–61 .
Attama AA Schicke BC Paepenmüller T Müller-Goymann CC . Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization. Eur J Pharm Biopharm. 2007; 67: 48–57 .
Attama AA Müller-Goymann CC . Effect of beewax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloids Surf A. 2008; 315: 189–95 .
Müller RH Runge SA Ravelli V Thünemann AF Mehnert W Souto EB . Cyclosporineloaded SLNs: drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm. 2008; 68: 535–44 .
Siekmann B Westesen K . Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surf B. 1994; 3: 159–75 .
Hou DZ Xie CS Huang KJ Zhu CH . The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 2003; 24: 1781–5 .
Westesen K Siekmann B Koch MHJ . Investigation on the physical state of lipid nanoparticles by synchrotron X-ray diffraction. Int J Pharm. 1993; 93: 189–99 .
Bunjes H Westesen K Koch MHJ . Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm. 1996; 129: 159–73 .